GlaxoSmithKline PLC Total Voting Rights (1516H)
01 Diciembre 2020 - 9:00AM
UK Regulatory
TIDMGSK
RNS Number : 1516H
GlaxoSmithKline PLC
01 December 2020
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure
Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the
'Company') hereby notifies the market of the following:
The Company's issued share capital as at 30 November 2020
consisted of 5,385,136,645 shares of 25 pence each ('Ordinary
Shares'), of which 367,705,950 Ordinary Shares were held in
Treasury.
Therefore, the total number of voting rights in the Company is
5,017,430,695. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
V A Whyte
Company Secretary
1 December 2020
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVRUPGUWPUPUGCG
(END) Dow Jones Newswires
December 01, 2020 10:00 ET (15:00 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024